What does CUSIP 16934W106 represent in this 13F holders report?

CUSIP 16934W106 is the security identifier for CMRX - CHIMERIX, INC. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

How many institutions held CMRX - CHIMERIX, INC. - Common Stock, par value $0.001 per share in Q1 2022?

122 institutional investors reported CMRX - CHIMERIX, INC. - Common Stock, par value $0.001 per share for Q1 2022. Use the holders table for investor-level position and value details.

CHIMERIX, INC. - Common Stock, par value $0.001 per share (CMRX)

CUSIP: 16934W106

Q1 2022 13F Holders as of 31 Mar 2022

Security type / class: Equity / Common Stock, par value $0.001 per share
Total 13F shares: 52,327,707
Total 13F value: $239,874,899
Share change: -2,786,620
Put/Call ratio: 19%
SEC-reported price per share: $4.58
Number of holders: 122
Value change: -$14,268,874
Number of buys: 50
Number of sells: 59
Shares outstanding: 94,458,399

Security key

16934W106

Report period

Q1 2022

Institutions

122

Top holders

CMRX full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2025 CHIMERIX INC SEC filings CHIMERIX INC company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 16934W106

Newer quarter: Q3 2025

Recent filing periods:

Q4 2025 Q3 2025

Ownership snapshot

Top reported holders of CMRX - CHIMERIX, INC. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

CANTEX PHARMACEUTICALS, INC.

Disclosed value leader

MSD Partners, L.P.

Comparable rows

0/15

Latest evidence

31 Dec 2021

3/4/5 13F Highest disclosed value: $38,580,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

MSD Partners, L.P. has the largest disclosed position value at $38.58M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens MSD Partners, L.P.'s linked filing trail.

Disclosed position value Top 5

CANTEX PHARMACEUTICALS, INC. $3.34M

MSD Partners, L.P. $38.58M

Opaleye Management Inc. $35.88M

BlackRock Finance, Inc. $34.6M

Rubric Capital Management LP $30.86M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
CANTEX PHARMACEUTICALS, INC.	3/4/5 10%+ Owner 3/4/5	— denominator unverified	$3,343,550 3,500,000 shares	—	14 Sep 2021
MSD Partners, L.P.	13F Company 13F	— denominator unverified	$38,580,000 6,000,000 shares	—	31 Dec 2021
Opaleye Management Inc.	13F Company 13F	— denominator unverified	$35,879,000 5,580,000 shares	—	31 Dec 2021
BlackRock Finance, Inc.	13F Company 13F	— denominator unverified	$34,602,000 5,381,236 shares	—	31 Dec 2021
Rubric Capital Management LP	13F Company 13F	— denominator unverified	$30,864,000 4,800,000 shares	—	31 Dec 2021
Point72 Asset Management, L.P.	13F Company 13F	— denominator unverified	$29,201,000 4,541,353 shares	—	31 Dec 2021

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

122

52,327,707

Rows available

122

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2022 vs Q3 2025 Across Filers

Q3 2025 holders

Q1 2022 holders

122

Holder diff

122

Investor	Q3 2025 Shares	Q1 2022 Shares	Share Diff	Share Chg %	Q3 2025 value	Q1 2022 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend